ImpaCt of aspirin regimen on THrombin generation in diabEtic patients with acute coronary syndrome: CARTHaGE-ACS trial.

Amine BoussofaraLaroussi LobnaHela BaccoucheEmna BennourSami KasbaouiHbib TrikiIbn El Haj ZiedIkram KammounAfef Ben HalimaFaouzi AddadSonia MarrakchiNeila Ben RomdhaneSalem Kachboura

Published in: European journal of clinical pharmacology (2020)

Only the twice-daily aspirin regimen led to better control of hypercoagulability in NSTE-ACS diabetic patients. However, no thrombin generation normalization was reported.

Keyphrases

acute coronary syndrome
antiplatelet therapy
low dose
cardiovascular events
percutaneous coronary intervention
type diabetes
study protocol
clinical trial
phase iii
phase ii
randomized controlled trial
cardiovascular disease